Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, December 16, 2015
Recipharm and LIDDS have signed an exclusive collaboration agreement regarding scale-up of the production process and commercial manufacture of Liproca® Depot, LIDDS patented targeted treatment for prostate cancer.
read more
Recipharm Karlskoga AB, specialized in the manufacture of semi-solid products, and Pharmanest
AB, a Stockholm-based pharmaceutical company specializing in developing products for local pain
relief in obstetrics and gynecology, are pleased to ...
read more
Wednesday, December 14, 2016
Recipharm has appointed Anders Högdin and Aaron Small to lead the growth of its pharmaceutical development services business in the US and Europe.
read more
Tuesday, January 11, 2022
Recipharm announced the sale to Astrea Pharma, the newly established CDMO provider focused on small molecule oral solid and aseptic dosages, of the solid dose manufacturing site at Fontaine-lès-Dijon, France.
read more
Recipharm has appointed Yves Buelens to the position of General Manager for its wholly owned new subsidiary Kaysersberg Pharmaceuticals SAS.
read more
Recipharm has announced the appointment of Anke Mollowitz to the role as Key Account Director. Anke has joined the Business Management team and is responsible for coordinating customer management and commercial aspects, as well as developing ...
read more
Recipharm has announced the appointment of a new business director for the Italian pharmaceutical market and a new General Manager at Pessac, France.
read more
Wednesday, April 12, 2017
Recipharm AB has announced the appointment of Henrik Stenqvist as Recipharm’s new Executive Vice President and Chief Financial Officer, effective on April 24, 2017. He will be based at the company’s headquarters in Stockholm, Sweden and reports to ...
read more
Wednesday, February 13, 2019
Recipharm has appointed a new director of business management for the USA and Canada.
read more
Recipharm has appointed Ann Flodin as General Manager of its wholly owned new subsidiary Recipharm Laboratories Inc. in Research Triangle Park, North Carolina, USA, formerly Cirrus Pharmaceuticals Inc.
read more
Wednesday, February 14, 2018
Recipharm has appointed Bernard Pluta to lead its new global development organization.
read more
Wednesday, March 27, 2024
Recipharm, a global leader in contract development and manufacturing, has announced two major milestones as part of its ongoing commitment to sustainability, underpinning the Group’s pledge to minimize its environmental impact.
read more
Friday, December 01, 2017
Recipharm AB announces that it has commenced the supply of commercial products to Roche and completed the acquisition of the manufacturing facility located in Spain.
read more
Wednesday, October 26, 2022
Global contract development and manufacturing organization (CDMO) Recipharm, has bolstered its sterile filling capabilities by investing in Lab+ technology for low volume blow-fill-seal (BFS) filling at its facility in Kaysersberg, France.
read more
Recipharm and Sanofi have completed the acquisition of Sanofi’s inhalation contract manufacturing business including a manufacturing facility located in Holmes Chapel, UK.
read more